thiorphan has been researched along with Nasal Obstruction in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Nasal Obstruction: Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lurie, A | 1 |
| Nadel, JA | 1 |
| Roisman, G | 1 |
| Siney, H | 1 |
| Dusser, DJ | 1 |
1 trial available for thiorphan and Nasal Obstruction
| Article | Year |
|---|---|
Role of neutral endopeptidase and kininase II on substance P-induced increase in nasal obstruction in patients with allergic rhinitis.
Topics: Administration, Intranasal; Administration, Oral; Adult; Airway Resistance; Analysis of Variance; Ci | 1994 |